ILiAD Biotechnologies Funding: $215M Raised, Series B (2026)
ILiAD Biotechnologies is based in Weston, Florida. It has raised $215M in total funding. Latest round: Series B.
ILiAD Biotechnologies funding overview
ILiAD Biotechnologies is based in Weston, Florida. ILiAD Biotechnologies has raised $215M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2026. The round record for ILiAD Biotechnologies runs through 2026; nothing later has been disclosed. Investors on record include RA Capital Management, Janus Henderson Investors, BNP Paribas Asset Management Alts, AI Life Sciences. 4 distinct backers are named across the disclosed rounds.
ILiAD Biotechnologies at a glance
Total raised
$215M
Latest round
Series B
Latest round date
February 2026
Headquarters
Weston, Florida
Notable investors
RA Capital Management, Janus Henderson Investors, BNP Paribas Asset Management Alts, AI Life Sciences
Frequently asked about ILiAD Biotechnologies funding
How much has ILiAD Biotechnologies raised?
ILiAD Biotechnologies has raised $215M in total disclosed funding across the rounds on record.
Who has invested in ILiAD Biotechnologies?
RA Capital Management, Janus Henderson Investors, BNP Paribas Asset Management Alts, AI Life Sciences are named among the investors backing ILiAD Biotechnologies.
What was the latest ILiAD Biotechnologies funding round?
The most recent disclosed round is a Series B, announced in February 2026.
Where is ILiAD Biotechnologies based?
ILiAD Biotechnologies is based in Weston, Florida.
When did ILiAD Biotechnologies last raise?
The last disclosed ILiAD Biotechnologies round closed in February 2026 at Series B.
ILiAD Biotechnologies totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Weston below to benchmark round size and investor mix.
